(Total Views: 439)
Posted On: 05/26/2021 3:44:49 PM
Post# of 154091
Quote:
At this point in time, why is CytoDyn allowing ANY entity to halve the known effective dosage?
The CD10 trial would be their guidance. If we had the full data set the board could probably figure out why those dosages were chosen. But unfortunately we don't have that data.
(3)
(1)
